Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
129.26
+1.51 (1.18%)
At close: Apr 28, 2026, 4:00 PM EDT
128.96
-0.30 (-0.23%)
After-hours: Apr 28, 2026, 7:01 PM EDT
Gilead Sciences Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for Gilead Sciences stock have an average target of 148.39, with a low estimate of 112 and a high estimate of 180. The average target predicts an increase of 14.80% from the current stock price of 129.26.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Gilead Sciences stock from 18 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 8 | 7 | 7 | 7 |
| Buy | 10 | 9 | 9 | 8 | 8 | 8 |
| Hold | 5 | 4 | 4 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 20 | 21 | 18 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $156 → $165 | Strong Buy | Maintains | $156 → $165 | +27.65% | Apr 13, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $171 → $175 | Buy | Maintains | $171 → $175 | +35.39% | Apr 10, 2026 |
| Jefferies | Jefferies | Strong Buy Initiates $180 | Strong Buy | Initiates | $180 | +39.25% | Mar 10, 2026 |
| Needham | Needham | Strong Buy Reiterates $170 | Strong Buy | Reiterates | $170 | +31.52% | Feb 23, 2026 |
| Barclays | Barclays | Hold Initiates $155 | Hold | Initiates | $155 | +19.91% | Feb 20, 2026 |
Financial Forecast
Revenue This Year
30.82B
from 29.44B
Increased by 4.68%
Revenue Next Year
32.68B
from 30.82B
Increased by 6.04%
EPS This Year
8.84
from 6.78
Increased by 30.40%
EPS Next Year
9.83
from 8.84
Increased by 11.20%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 32.4B | 35.5B | ||||||
| Avg | 30.8B | 32.7B | ||||||
| Low | 29.1B | 30.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 10.0% | 15.3% | ||||||
| Avg | 4.7% | 6.0% | ||||||
| Low | -1.0% | -1.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 9.35 | 11.19 | ||||||
| Avg | 8.84 | 9.83 | ||||||
| Low | 8.12 | 8.08 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 37.8% | 26.6% | ||||||
| Avg | 30.4% | 11.2% | ||||||
| Low | 19.8% | -8.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.